Abstract
GATA-1 and c-Myb transcription factors represent key regulators of red blood cell development. GATA-1 is upregulated and c-myb proto-oncogene expression is downregulated when red cell progenitors differentiate into erythrocytes. Here we have employed a culture system, that faithfully recapitulates red blood cell differentiation in vitro, to follow the kinetics of GATA-1 and c-myb expression. We show that c-myb proto-oncogene expression is high in progenitors and effectively downregulated at the time when nuclear GATA-1 accumulates and cells differentiate into erythrocytes. Additionally, we identified two GATA-1 binding sites within the c-myb promoter and demonstrate that GATA-1 protein binds to these sites in vitro. Furthermore, GATA-1 represses c-myb expression through one of the GATA-1 binding sites in transient transfection experiments and this requires FOG-1. Thus, our study provides evidence for a direct molecular link between GATA-1 activity and c-myb proto-oncogene expression during terminal red cell differentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aird WC, Parvin JD, Sharp PA and Rosenberg RD . (1994). J. Biol. Chem., 269, 883–889.
Bartunek P, Karafiat V, Dvorakova M, Zahorova V, Mandikova S, Zenke M and Dvorak M . (1997). Oncogene, 15, 2939–2949.
Bartunek P and Zenke M . (1998). Mol. Endocrinol., 12, 1269–1279.
Bartunek P, Pajer P, Karafiat V, Blendinger G, Dvorak M and Zenke M . (2002). Oncogene, 21, 400–410.
Bartunek P, Kozmik Z and Dvorak M . (1992). Virology, 190, 882–883.
Bartunek P, Pichlikova L, Stengl G, Boehmelt G, Martin FH, Beug H, Dvorak M and Zenke M . (1996). Cytokine, 8, 14–20.
Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G and Beug H . (1998). EMBO J., 17, 4291–4303.
Bellon T, Perrotti D and Calabretta B . (1997). Blood, 90, 1828–1839.
Beug H, Steinlein P, Bartunek P and Hayman MJ . (1995). Methods Enzymol., 254, 41–76.
Boyes J, Byfield P, Nakatani Y and Ogryzko V . (1998). Nature, 396, 594–598.
Briegel K, Bartunek P, Stengl G, Lim KC, Beug H, Engel JD and Zenke M . (1996). Development, 122, 3839–3850.
Briegel K, Lim KC, Plank C, Beug H, Engel JD and Zenke M . (1993). Genes Dev., 7, 1097–1109.
Campanero MR, Armstrong M and Flemington E . (1999). Mol. Cell. Biol., 19, 8442–8450.
Chiba T, Ikawa Y and Todokoro K . (1991). Nucleic Acids Res., 19, 3843–3848.
Crossley M and Orkin SH . (1994). J. Biol. Chem., 269, 16589–16596.
Cuddihy AE, Brents LA, Aziz N, Bender TP and Kuehl WM . (1993). Mol. Cell. Biol., 13, 3505–3513.
Deconinck AE, Mead PE, Tevosian SG, Crispino JD, Katz SG, Zon LI and Orkin SH . (2000). Development, 127, 2031–2040.
Dignam JD, Lebovitz RM and Roeder RG . (1983). Nucleic Acids Res., 11, 1475–1489.
Disela C, Glineur C, Bugge T, Sap J, Stengl G, Dodgson J, Stunnenberg H, Beug H and Zenke M . (1991). Genes Dev., 5, 2033–2047.
Dolznig H, Bartunek P, Nasmyth K, Mullner EW and Beug H . (1995). Cell Growth Differ., 6, 1341–1352.
Dolznig H, Boulme F, Stangl K, Deiner EM, Mikulits W, Beug H and Mullner EW . (2001). FASEB. J., 15, 1442–1444.
Dolznig H, Habermann B, Stangl K, Deiner EM, Moriggl R, Beug H and Mullner EW . (2002). Curr. Biol., 12, 1076–1085.
Dvorak M, Urbanek P, Bartunek P, Paces V, Vlach J, Pecenka V, Arnold L, Travnicek M and Riman J . (1989). Nucleic Acids Res., 17, 5651–5664.
Evans T and Felsenfeld G . (1989). Cell, 58, 877–885.
Fibach E, Manor D, Treves A and Rachmilewitz EA . (1991). Int. J. Cell Cloning, 9, 57–64.
Fong TC and Emerson BM . (1992). Genes Dev., 6, 521–532.
Graf T . (2002). Blood, 99, 3089–3101.
Grasser FA, Graf T and Lipsick JS . (1991). Mol. Cell. Biol., 11, 3987–3996.
Ko LJ and Engel JD . (1993). Mol. Cell. Biol., 13, 4011–4022.
Kozmik Z and Paces V . (1990). Gene, 90, 287–291.
Lyon JJ and Watson RJ . (1995). Differentiation, 59, 171–178.
McCann S, Sullivan J, Guerra J, Arcinas M and Boxer LM . (1995). J. Biol. Chem., 270, 23785–23789.
Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ and Potter SS . (1991). Cell, 65, 677–689.
Ness SA and Engel JD . (1994). Curr. Opin. Genet. Dev., 4, 718–724.
Nicolaides NC, Correa I, Casadevall C, Travali S, Soprano KJ and Calabretta B . (1992). J. Biol. Chem., 267, 19665–19672.
Nicolaides NC, Gualdi R, Casadevall C, Manzella L and Calabretta B . (1991). Mol. Cell. Biol., 11, 6166–6176.
Nordeen SK . (1988). Biotechniques, 6, 454–458.
Orkin SH . (1995). Curr. Opin. Cell Biol., 7, 870–877.
Panzenbock B, Bartunek P, Mapara MY and Zenke M . (1998). Blood, 92, 3658–3668.
Perrotti D, Melotti P, Skorski T, Casella I, Peschle C and Calabretta B . (1995). Mol. Cell. Biol., 15, 6075–6087.
Pevny L, Lin CS, D'Agati V, Simon MC, Orkin SH and Costantini F . (1995). Development, 121, 163–172.
Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH and Costantini F . (1991). Nature, 349, 257–260.
Simon MC, Pevny L, Wiles MV, Keller G, Costantini F and Orkin SH . (1992). Nat. Genet., 1, 92–98.
Sobieszczuk PW, Gonda TJ and Dunn AR . (1989). Nucleic Acids Res., 17, 9593–9611.
Sullivan J, Feeley B, Guerra J and Boxer LM . (1997). J. Biol. Chem., 272, 1943–1949.
Tsai SF, Martin DI, Zon LI, D'Andrea AD, Wong GG and Orkin SH . (1989). Nature, 339, 446–451.
Tsang AP, Fujiwara Y, Hom DB and Orkin SH . (1998). Genes Dev., 12, 1176–1188.
Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M and Orkin SH . (1997). Cell, 90, 109–119.
Urbanek P, Dvorak M, Bartunek P, Pecenka V, Paces V and, Travnicek M . (1988). Nucleic Acids Res., 16, 11521–11530.
von Lindern M, Zauner W, Mellitzer G, Steinlein P, Fritsch G, Huber K, Lowenberg B and Beug H . (1999). Blood, 94, 550–559.
Weiss MJ, Keller G and Orkin SH . (1994). Genes Dev., 8, 1184–1197.
Weiss MJ and Orkin SH . (1995). Exp. Hematol., 23, 99–107.
Wessely O, Deiner E-M, Beug H and von Lindern M . (1997). EMBO J., 16, 267–280.
Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH and Engel JD . (1990). Genes Dev., 4, 1650–1662.
Zenke M, Munoz A, Sap J, Vennstrom B and Beug H . (1990). Cell, 61, 1035–1049.
Zhang D, Johnson MM, Miller CP, Pircher TJ, Geiger JN and Wojchowski DM . (2001). Exp. Hematol., 29, 1278–1288.
Acknowledgements
We thank SH Orkin and H Wolfes for FOG-1 cDNA and expression plasmid, H Stunnenberg for His-huTBP, JD Engel for GST-GATA-1 and pLucβTATA, RH Nicolas for GATA-1 specific antibody and P Podlatis for expert secretarial assistance. Part of this work was funded by grants of the Grant Agency of the Czech Republic (301/98/K042) to MD, the Fonds der Chemischen Industrie to MZ and Volkswagen Foundation to PB and MZ.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bartůněk, P., Králová, J., Blendinger, G. et al. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene 22, 1927–1935 (2003). https://doi.org/10.1038/sj.onc.1206281
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206281
Keywords
This article is cited by
-
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Oncogenesis (2021)
-
Mechanisms of tRNA-derived fragments and tRNA halves in cancer treatment resistance
Biomarker Research (2020)
-
Substitution of Thr572 to Ala in mouse c-Myb attenuates progression of early erythroid differentiation
Scientific Reports (2020)
-
The development and maintenance of resident macrophages
Nature Immunology (2016)
-
Kit transduced signals counteract erythroid maturation by MAPK-dependent modulation of erythropoietin signaling and apoptosis induction in mouse fetal liver
Cell Death & Differentiation (2015)